MACROFENCE 1.25 G + 0.56 G, MEDICATED COLLAR FOR CATS
MACROFENCE 1.25 G + 0.56 G, MEDICATED COLLAR FOR CATS
Authorised
- Imidacloprid
- Flumethrin
Product identification
Medicine name:
MACROFENCE 1.25 G + 0.56 G, MEDICATED COLLAR FOR CATS
Macrofence 1,25 g + 0,56 g, coleira medicamentosa para gatos
Active substance:
- Imidacloprid
- Flumethrin
Target species:
-
Cat
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Imidacloprid1.25/gram(s)1.00Collar
-
Flumethrin0.56/gram(s)1.00Collar
Pharmaceutical form:
-
Medicated collar
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC55
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- Carton box containing one 38 cm polyvinyl chloride based collar individually packed into a PP/Aluminium/PET sachet.
- Carton box containing two 38 cm polyvinyl chloride based collars individually packed into a PP/Aluminium/PET sachet.
- Carton box containing twelve 38 cm polyvinyl chloride based collars individually packed into a PP/Aluminium/PET sachet.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
- Ab7 Sante
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 1743/01/25DFVPT
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0508/001
Concerned member states:
-
Italy
-
Netherlands
-
Portugal
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Portuguese (PDF)
Published on: 21/10/2025